1. The HCV Revolution: Are You and Your Practice Ready?

3. This program will include a discussion of data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.

4. The Importance of Recognizing HCV

5. Treating Patients in the Interferon Era

6. The DAA Era -- Path to the Cure First Generation

7. The DAA Era -- Path to the Cure First Generation (cont)

8. The DAA Era -- Path to the Cure Second Generation

9. The DAA Era -- Path to the Cure Second Generation (cont)

10. The DAA Era -- Path to the Cure Third Generation

11. The DAA Era -- Path to the Cure Practical Considerations

12. Guidelines for Treatment of Chronic HCV Infection

13. HCV-TARGET

14. Efficacy of DAAs in Clinical Practice Clinical Trial Data vs Real-World Experience

15. Real-World Data Build Confidence

16. Caring for Patients in the Current Era The Opportunity Is Here, the Time Is Now

17. New HCV Infections Nearly Tripled Over 5 Years

18. Changing Demographics The "Second Bump"

19. Support Services for Effective Treatment Outcomes

20. Treating HCV in People Who Inject Drugs Debunking the Myths

21. Treating HCV in People Who Inject Drugs What Do the Data Show?

22. Treating People Who Inject Drugs Practical Realities

23. Some Patients Will Need to Be Referred

24. Get Started It’s Not Difficult, and It’s Very Rewarding

25. Practical Strategies for Making HCV Care a Part of Your Practice

26. Concluding Remarks

27. Abbreviations